Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP951605priorityCriticalpatent/ECSP951605A/es
Publication of ECSP951605ApublicationCriticalpatent/ECSP951605A/es
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Peptides Or Proteins
(AREA)
Preparation Of Compounds By Using Micro-Organisms
(AREA)
Abstract
El invento hace referencia a la de la preparación de fragmentos de anticuerpos monoclonales monovalentes (Fab.) de anticuerpos monoclonales (mab) que tiene la capacidad de reducir la sensibilidad de la expresión del sistema HLA - DR en células precursoras del antígeno.
ECSP9516051995-12-071995-12-07Fragmentos de anticuerpos monoclonales que tienen actividad inmunosupresora, case ran 4105/171
ECSP951605A
(es)
Monoklonalt antistoff som spesifikt gjenkjenner n-glycolyl type gm2, hybridom som produserer antistoff og fremgangsmaate for fremstilling av hybridomet.